Sugi Predict

Sugi Predict / Compounds / SCHEMBL6740146

SCHEMBL6740146

SCHEMBL6740146

CC(C)(C)OC(=O)[C@H](N)CCC(=O)O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 2/20 0.52
▸ GRM8 O00222 1/20 0.52
▸ GRM6 O15303 1/20 0.52
▸ GRIN2D O15399 1/20 0.52
▸ GRIN3B O60391 1/20 0.52
▸ GSR P00390 1/20 0.52
▸ GRIK1 P39086 1/20 0.52
▸ GRM5 P41594 1/20 0.52
▸ GRIA1 P42261 1/20 0.52
▸ GRIA2 P42262 1/20 0.52
▸ GRIA3 P42263 1/20 0.52
▸ SLC1A3 P43003 1/20 0.52
▸ SLC1A2 P43004 1/20 0.52
▸ SLC1A1 P43005 1/20 0.52
▸ GRIA4 P48058 1/20 0.52
▸ GRIN1 Q05586 1/20 0.52
▸ GRIN2A Q12879 1/20 0.52
▸ GRIK2 Q13002 1/20 0.52
▸ GRIK3 Q13003 1/20 0.52
▸ GRIN2B Q13224 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL561334 1.00 CYP1A2 (0.52) CYP1A2GRM8GRM6GRIN2DGRIN3B
SCHEMBL337707 1.00 CYP1A2 (0.52) CYP1A2GRM8GRM6GRIN2DGRIN3B
Hydrochloric Acid SCHEMBL3580142 0.98 CYP1A2 (0.50) CYP1A2GRM8GRM6GRIN2DGRIN3B
Hydrochloric Acid SCHEMBL2124740 0.98 CYP1A2 (0.50) CYP1A2GRM8GRM6GRIN2DGRIN3B
Hydrochloric Acid SCHEMBL2124734 0.98 CYP1A2 (0.50) CYP1A2GRM8GRM6GRIN2DGRIN3B
SCHEMBL28096244 0.98 CYP1A2 (0.50) CYP1A2GRM8GRM6GRIN2DGRIN3B
SCHEMBL15888382 0.90 GABRP (0.41) CYP1A2GRM8GRM6GRIN2DGRIN3B
SCHEMBL30439764 0.89 ENPEP (0.43) CYP1A2GRM8GRM6GRIN2DGRIN3B
SCHEMBL2218974 0.89 ENPEP (0.43) CYP1A2GRM8GRM6GRIN2DGRIN3B
Aminocaproic Acid SCHEMBL5709467 0.87 LMNA (0.50) CYP1A2GRM8GRM6GRIN2DGRIN3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115894395-A Preparation method of cycleanine derivative 康化（上海）新药研发有限公司 2023-04-04 — — CN claimed
CN-115368234-A Synthesis method of important intermediate of Somaloutide side chain 淄博矿业集团有限责任公司 2022-11-22 — — CN claimed
CN-112679701-B Immobilized lysine endopeptidase and preparation method and application thereof 重庆宸安生物制药有限公司 2022-02-25 — — CN claimed
US-12576169-B2 Silicon-fluoride acceptor substituted radiopharmaceuticals and precursors thereof Technische Universität München (DE) 2026-03-17 — — US disclosed
EP-4425181-A1 COMPOSITION FOR DETECTING OR MEASURING ANALYTE Bertis Inc (KR) 2024-09-04 — — EP disclosed
CN-111032676-B Antibody drug complexes comprising hamiltin derivatives 住友制药株式会社 2024-08-23 — — CN disclosed
CN-113677375-B Silicon fluoride receptor substituted radiopharmaceuticals and precursors thereof 慕尼黑工业大学 2024-07-23 — — CN disclosed
CN-115368234-B Synthetic method of cable Ma Lutai side chain and intermediate thereof 淄博矿业集团有限责任公司 2024-01-26 — — CN disclosed
US-20240011979-A1 COMPOSITION FOR DETECTING OR MEASURING ANALYTES BERTIS INC. (KR) 2024-01-11 — — US disclosed
CN-116829949-A Compositions for detecting or measuring analytes 伯蒂斯有限公司 2023-09-29 — — CN disclosed
CN-116426508-A Recombinant lysyl endopeptidase mutant and application thereof 重庆艾美迪生物科技有限公司 2023-07-14 — — CN disclosed
CN-115368234-A Synthesis method of important intermediate of Somaloutide side chain 淄博矿业集团有限责任公司 2022-11-22 — — CN disclosed
US-20220283131-A1 COMPOSITION FOR DETECTING OR MEASURING ANALYTES BERTIS CO., LTD. (KR) 2022-09-08 — — US disclosed
US-20220096669-A1 SILICON-FLUORIDE ACCEPTOR SUBSTITUTED RADIOPHARMACEUTICALS AND PRECURSORS THEREOF Technische Universität München (DE) 2022-03-31 — — US disclosed
WO-2022050529-A1 COMPOSITION FOR DETECTING OR MEASURING ANALYTE ㈜베르티스 2022-03-10 — — WO disclosed
CN-112679701-B Immobilized lysine endopeptidase and preparation method and application thereof 重庆宸安生物制药有限公司 2022-02-25 — — CN disclosed
CN-112679701-B Immobilized lysine endopeptidase and preparation method and application thereof 重庆宸安生物制药有限公司 2022-02-25 — — CN disclosed
US-20040225006-A1 (Hetero) bicyclymethanesulfonylamino-substituted hydroxamic acid derivates SMITHKLINE BEECHAM P.L.C. 2004-11-11 — — US disclosed
US-20030199571-A1 (Hetero) Bicyclymethanesulfonylamino-substituted hydroxamic acid derivatives SMITHKLINE BEECHAM P.L.C. (GB) 2003-10-23 — — US disclosed
US-5108990-A GLUTAMIC ACID DERIVATIVES ROUSSEL UCLAF (FR) 1992-04-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220096669-A1 SILICON-FLUORIDE ACCEPTOR SUBSTITUTED RADIOPHARMACEUTICALS AND PRECURSORS THEREOF FOLH1, KLK3, FRS2 CYP1A2 4670/4885GRM8 1914/4885GRM6 1486/4885
US-20030199571-A1 (Hetero) Bicyclymethanesulfonylamino-substituted hydroxamic acid derivatives CD40, CD22, CD2 CYP1A2 1062/4885GRM8 4044/4885GRM6 1896/4885
US-20040225006-A1 (Hetero) bicyclymethanesulfonylamino-substituted hydroxamic acid derivates CD40, TNFRSF1A, CD2 CYP1A2 1222/4885GRM8 3693/4885GRM6 1666/4885
US-12576169-B2 Silicon-fluoride acceptor substituted radiopharmaceuticals and precursors thereof KLK3, FOLH1, SLC7A1 CYP1A2 4726/4885GRM8 947/4885GRM6 780/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.